Raymond James & Associates’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,281
| Closed | -$587K | – | 3905 |
|
|
2023
Q2 | $587K | Buy |
15,281
+1,404
| +10% | +$53.9K | ﹤0.01% | 2812 |
|
|
2023
Q1 | $321K | Buy |
13,877
+34
| +0.2% | +$787 | ﹤0.01% | 3167 |
|
|
2022
Q4 | $363K | Sell |
13,843
-214
| -2% | -$5.61K | ﹤0.01% | 3087 |
|
|
2022
Q3 | $276K | Buy |
14,057
+339
| +2% | +$6.66K | ﹤0.01% | 3219 |
|
|
2022
Q2 | $240K | Buy |
+13,718
| New | +$240K | ﹤0.01% | 3367 |
|
|
2020
Q4 | – | Sell |
-4,690
| Closed | -$57K | – | 3722 |
|
|
2020
Q3 | $57K | Hold |
4,690
| – | – | ﹤0.01% | 3386 |
|
|
2020
Q2 | $54K | Hold |
4,690
| – | – | ﹤0.01% | 3315 |
|
|
2020
Q1 | $64K | Hold |
4,690
| – | – | ﹤0.01% | 3254 |
|
|
2019
Q4 | $28K | Hold |
4,690
| – | – | ﹤0.01% | 3515 |
|
|
2019
Q3 | $25K | Hold |
4,690
| – | – | ﹤0.01% | 3457 |
|
|
2019
Q2 | $36K | Hold |
4,690
| – | – | ﹤0.01% | 3460 |
|
|
2019
Q1 | $93K | Hold |
4,690
| – | – | ﹤0.01% | 3367 |
|
|
2018
Q4 | $62K | Hold |
4,690
| – | – | ﹤0.01% | 3336 |
|
|
2018
Q3 | $172K | Hold |
4,690
| – | – | ﹤0.01% | 3309 |
|
|
2018
Q2 | $164K | Hold |
4,690
| – | – | ﹤0.01% | 3297 |
|
|
2018
Q1 | $218K | Sell |
4,690
-9
| -0.2% | -$418 | ﹤0.01% | 3070 |
|
|
2017
Q4 | $176K | Buy |
4,699
+9
| +0.2% | +$337 | ﹤0.01% | 3078 |
|
|
2017
Q3 | $250K | Sell |
4,690
-40
| -0.8% | -$2.13K | ﹤0.01% | 2889 |
|
|
2017
Q2 | $270K | Buy |
4,730
+40
| +0.9% | +$2.28K | ﹤0.01% | 2773 |
|
|
2017
Q1 | $252K | Hold |
4,690
| – | – | ﹤0.01% | 2788 |
|
|
2016
Q4 | $267K | Sell |
4,690
-20
| -0.4% | -$1.14K | ﹤0.01% | 2687 |
|
|
2016
Q3 | $293K | Buy |
+4,710
| New | +$293K | ﹤0.01% | 2630 |
|